Firefly Neuroscience Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

false 0000803578 0000803578 2024-12-30 2024-12-30

 

 

 

Date of Report (Date of earliest event reported): December 30, 2024

 

 

 

 

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.                            

Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.02         Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On December 30, 2024, Jon Olsen resigned from his position as a member of the board of directors (the “Board”) of Firefly Neuroscience, Inc. (the “Company”), effective immediately.  Mr. Olsen’s resignation was not related to any disagreement regarding the Company’s operations, policies or practices.

 

In addition, on January 6, 2025, the Board removed Mr. Olsen from his position as the Company’s Chief Executive Officer without cause and appointed Greg Lipschitz as the Company’s Interim Chief Executive Officer.

 

Item 9.01                  Financial Statements and Exhibits.

 

(d) Exhibits

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.